OHSU neurogeneticist Brian J. O'Roak, Ph.D., is one of a select group of researchers in the United States and Canada to be honored with a 2015 Alfred P. Sloan Research Fellowship.
Raymond Bergan, M.D. — an internationally regarded cancer specialist known for leading breakthrough studies on how cancer cells spread and preventive treatments for high risk patients — has joined Oregon Health & Science University (OHSU) as head of Hematology & Medical Oncology in the School of Medicine and associate director of medical oncology for the OHSU Knight Cancer Institute.
Treatment with the hormone progesterone provided no significant benefits to patients who had suffered a traumatic brain injury, according to the results of a nationwide clinical trial involving more than 800 patients.
A therapy currently under development for spinal cord injuries has been shown to stimulate nerve regeneration in the heart and provide resistance to arrhythmias following a heart attack, according to a new study published today in the journal Nature Communications.
The OHSU Knight Cardiovascular Institute and Edwards Lifesciences, the global leader in the science of heart valves and hemodynamic monitoring, today announced the launch of the Starr Educational Training Program, a technical training program that provides medical device engineers at Edwards with in-person clinical experiences, as well as a forum for cardiologists and engineers to discuss patient selection, obstacles and approaches to procedures.
A large international group of scientists, including an Oregon Health & Science University neuroscientist, is publishing this week the results of a first-ever look at the genome of dozens of common birds. The scientists’ research tells the story of ...
A new study published online today in the journal Nature identifies 27 genes that, if mutated, will either cause autism or contribute to its risk. The study is the most comprehensive look at the genomes of parents and children where one child is ...
Oregon Health & Science University's Vaccine & Gene Therapy Institute (OHSU) has been awarded a $10 million contract from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH). Kineta, Inc., ...
Oregon Health & Science University researchers have received a $25 million grant from the Bill & Melinda Gates Foundation to advance work on a promising vaccine candidate that may someday prevent or cure infection with HIV, the virus that causes AIDS. ...
The international Cochrane Collaboration — the world's leading organization for conducting systematic reviews on what works in health care — announced today that its new West Coast branch of the U.S. Cochrane Center will be at Oregon Health & Science ...